Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.14670/HH-18-189

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorSanguedolce, Francesca-
dc.contributor.authorCormio, Luigi-
dc.contributor.authorCarrieri, Giuseppe-
dc.contributor.authorCalò, Beppe-
dc.contributor.authorRusso, Davide-
dc.contributor.authorMenin, Andrea-
dc.contributor.authorPastore, Antonio Luigi-
dc.contributor.authorGreco, Francesco-
dc.contributor.authorBozzini, Giorgio-
dc.contributor.authorGalfano, Antonio-
dc.contributor.authorPini, Giovannalberto-
dc.contributor.authorPorreca, Angelo-
dc.contributor.authorMugavero, Filippo-
dc.contributor.authorFalsaperla, Mario-
dc.contributor.authorCeruti, Carlo-
dc.contributor.authorCindolo, Luca-
dc.contributor.authorAntonelli, Alessandro-
dc.contributor.authorMinervini, Andrea-
dc.date.accessioned2022-11-17T09:21:23Z-
dc.date.available2022-11-17T09:21:23Z-
dc.date.issued2020-
dc.identifier.citationHistology and Histopathology Vol. 35, nº5 (2020)es
dc.identifier.issn0213-3911-
dc.identifier.issn1699-5848-
dc.identifier.urihttp://hdl.handle.net/10201/125684-
dc.description.abstractIn order to evaluate the potential prognostic/predictive role of androgen receptor (AR) expression in non-muscle-invasive bladder cancer (NMIBC), and whether it may represent a therapeutic target, we conducted a systematic search of the literature using ‘androgen receptor or AR’, ‘testosterone’, ‘bladder cancer’ and ‘non-muscle invasive bladder cancer or NMIBC’ as keywords. Eleven studies met the inclusion/exclusion criteria. No significant association was found between AR status and patients’ gender (p=0.232), tumor size (p=0.975), tumor stage (p=0.237), tumor grade (p=0.444), tumor multicentricity (p=0.397), concomitant CIS (p=0.316) and progression of disease (p=0.397). On the other hand, relative lack of AR expression was significantly correlated to recurrent disease (p=0.001). Evidence for a direct correlation between AR expression and recurrence-free survival of patients with NMIBC indicate ARs as potential markers of BC behavior; moreover, the finding of a role of androgen blockade therapy in improving survival highlights the potential clinical application of this pathway, which deserves to be further explored.es
dc.formatapplication/pdfes
dc.format.extent10es
dc.languageenges
dc.publisherUniversidad de Murcia, Departamento de Biologia Celular e Histiologiaes
dc.relationSin financiación externa a la Universidades
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAndrogen receptores
dc.subjectNon-muscle-invasive bladder canceres
dc.subjectImmunohistochemistryes
dc.subjectPrognosises
dc.subjectBiomarkerses
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleRole of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysises
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doihttps://doi.org/10.14670/HH-18-189-
Aparece en las colecciones:Vol.35, nº5 (2020)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Sanguedolce-35-423-432-2020.pdf2,27 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons